CELLVIE Trademark

Trademark Overview

On Wednesday, October 21, 2020, a trademark application was filed for CELLVIE with the United States Patent and Trademark Office. The USPTO has given the CELLVIE trademark a serial number of 90270097. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 5, 2023. This trademark is owned by TDB IP Holding, LLC. The CELLVIE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Intravenous (IV) vitamin therapy services
cellvie

General Information

Serial Number90270097
Word MarkCELLVIE
Filing DateWednesday, October 21, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 5, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements

Goods and ServicesIntravenous (IV) vitamin therapy services

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 10, 2020
Primary Code044
First Use Anywhere DateWednesday, October 21, 2020
First Use In Commerce DateMonday, May 23, 2022

Trademark Owner History

Party NameTDB IP Holding, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWrentham, MA 02093
Party NameTDB IP Holding, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWrentham, MA 02093

Trademark Events

Event DateEvent Description
Tuesday, September 5, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, September 5, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, September 5, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 22, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, May 22, 2023FINAL REFUSAL E-MAILED
Monday, May 22, 2023SU - FINAL REFUSAL - WRITTEN
Monday, April 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 24, 2023ASSIGNED TO LIE
Wednesday, January 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 25, 2022NON-FINAL ACTION E-MAILED
Monday, July 25, 2022SU - NON-FINAL ACTION - WRITTEN
Tuesday, June 7, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, May 23, 2022USE AMENDMENT FILED
Tuesday, June 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 23, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, November 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 22, 2021NON-FINAL ACTION E-MAILED
Monday, February 22, 2021NON-FINAL ACTION WRITTEN
Wednesday, February 10, 2021ASSIGNED TO EXAMINER
Wednesday, February 10, 2021ASSIGNED TO EXAMINER
Thursday, December 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 24, 2020NEW APPLICATION ENTERED

Related Keywords

cellvie services therapy vitamin intravenous